FDA Inspection 1158989 — Lin Shen, M.D.

Lin Shen, M.D. — FEI 3019956301

The FDA completed an inspection of Lin Shen, M.D. on November 24, 2021 in Haidian District. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 24, 2021
Fiscal Year
2022
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Haidian District (China)

Additional Details

Clinical Investigator (CI)